Post hoc exploratory analysis of ZEDS (527 adults with herpes zoster ophthalmicus): 12 months of valacyclovir vs placebo showed non-significantly lower hazards of keratitis or iritis, at 0–12 months (HR 0.77) and >12–18 months (HR 0.57).
Secondary analysisn = 527
Warner et al. Time-Varying Effects of Valacyclovir Prophylaxis in the Zoster Eye Disease Study: A Post Hoc Exploratory Analysis of a Randomized Clinical Trial